Utilizing Longitudinal Within-Individual Changes of Serum Creatinine, Cystatin C, and/or eGFR to Optimize Clinical Sensitivity and Eliminate Race and Gender Corrections
J Appl Lab Med
.
2022 May 4;7(3):807-811.
doi: 10.1093/jalm/jfac001.
Authors
John G Toffaletti
1
,
Cyril O Burke
2
,
George Bayliss
3
,
Matthew Lynch
3
Affiliations
1
Duke University Medical Center, Department of Pathology/Clinical Laboratories, Durham, NC, USA.
2
Alpert-Brown Medical School, Medical Staff at The Miriam Hospital, Providence, RI, USA.
3
Department of Medicine, Division of Kidney Disease & Hypertension, Alpert-Brown Medical School, Rhode Island Hospital, Providence, RI, USA.
PMID:
35138380
DOI:
10.1093/jalm/jfac001
No abstract available
MeSH terms
Creatinine
Cystatin C*
Glomerular Filtration Rate
Humans
Substances
Cystatin C
Creatinine